ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 88 filers reported holding ONCOCYTE CORP in Q1 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $12,325 | -41.4% | 34,776 | -47.0% | 0.00% | – |
| Q4 2022 | $21,048 | -88.2% | 65,592 | -67.0% | 0.00% | – |
| Q2 2022 | $179,000 | +47.9% | 198,704 | +144.7% | 0.00% | – |
| Q1 2022 | $121,000 | -80.2% | 81,200 | -71.3% | 0.00% | – |
| Q4 2021 | $612,000 | +20.5% | 282,614 | +98.4% | 0.00% | – |
| Q3 2021 | $508,000 | -25.2% | 142,423 | +20.5% | 0.00% | – |
| Q2 2021 | $679,000 | -34.0% | 118,200 | -40.4% | 0.00% | – |
| Q1 2021 | $1,029,000 | +259.8% | 198,281 | +65.4% | 0.00% | – |
| Q4 2020 | $286,000 | +232.6% | 119,880 | +93.7% | 0.00% | – |
| Q3 2020 | $86,000 | +95.5% | 61,887 | +245.2% | 0.00% | – |
| Q1 2020 | $44,000 | -15.4% | 17,926 | -23.1% | 0.00% | – |
| Q4 2019 | $52,000 | -40.2% | 23,312 | -43.5% | 0.00% | – |
| Q3 2019 | $87,000 | -77.8% | 41,251 | -73.7% | 0.00% | – |
| Q2 2019 | $392,000 | +243.9% | 156,841 | +441.6% | 0.00% | – |
| Q1 2019 | $114,000 | +137.5% | 28,961 | +178.8% | 0.00% | – |
| Q4 2017 | $48,000 | -35.1% | 10,386 | -16.9% | 0.00% | – |
| Q1 2017 | $74,000 | – | 12,505 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 17,349,945 | $61,766,000 | 3.15% |
| Defender Capital, LLC. | 1,960,820 | $6,935,000 | 2.26% |
| Millrace Asset Group, Inc. | 613,885 | $2,185,000 | 1.36% |
| PURA VIDA INVESTMENTS, LLC | 12,223,953 | $43,517,000 | 1.32% |
| Penbrook Management LLC | 577,200 | $2,055,000 | 1.28% |
| ACT CAPITAL MANAGEMENT, LLC | 330,000 | $1,175,000 | 0.61% |
| AWM Investment Company, Inc. | 717,000 | $2,553,000 | 0.25% |
| Colonial River Wealth Management, LLC | 66,200 | $218,000 | 0.15% |
| CALIBER WEALTH MANAGEMENT, LLC | 66,200 | $218,000 | 0.15% |
| Fort Sheridan Advisors LLC | 110,000 | $392,000 | 0.13% |